S&P Global Withdraws Canopy Growth’s Credit Ratings At Company’s Request

S&P Global Inc. has complied with a request from Canopy Growth Corp. (TSX: WEED) to withdraw its credit ratings following the cannabis company’s decision to amend a 2022 credit agreement.

The New York-based ratings and research firm had previously given Canopy a “selective default” rating on its long-term issuer credit, indicating the company had failed to meet one or more of its financial obligations on time.

The change stems from an October 2022 amendment to Canopy’s term loan credit agreement, which eliminated the need for ratings from two agencies. A Canopy representative told Bloomberg that the move is part of the company’s ongoing efforts to streamline resources, which led to the decision to withdraw its public rating with S&P.

PTX Metals Inc. — sponsored Sponsored · PTX Metals Inc.

Presently, Canopy holds a “CCC-” rating from Fitch Ratings, after getting downgraded in October 2022. Fitch’s decision was based on a perceived significant reduction in the financial ties between Canopy and its main investor, Constellation Brands Inc.

This withdrawal from S&P follows Canopy’s recent voluntary application for a management cease trade order with various regulatory bodies, following the need to refile several quarters worth of financial statements due to problems with the accuracy of reported figures for its BioSteel Sports Nutrition segment.

Originally, Canopy had intended to release its year-end fiscal 2023 financial results earlier this week.

Canopy Growth Corp. last traded at $1.18 on the TSX.


Information for this briefing was found via Bloomberg. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Building the $500M-a-Year Gold Mine | Victor Cantore – Amex Gold Mining

Building the Next 500,000-Ounce Gold Producer | Stephen Soock – Heliostar Metals

This Gold Explorer Is Making Its Biggest Bet | Brian Miller – Astra Exploration

Recommended

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Related News

RFK Jr. Is Now US Health Secretary, Warns of ‘Catastrophic Impacts’ of Cannabis

Newly confirmed US Health Secretary Robert F. Kennedy Jr. warns cannabis poses “catastrophic impacts” on...

Friday, February 14, 2025, 11:56:00 AM

Canaccord Genuity Reportedly Suspends Cannabis Coverage

Investment bank Canaccord Genuity has reportedly suspended research coverage of 15 cannabis companies following an...

Monday, July 21, 2025, 12:54:00 PM

The Deep Dive’s Canopy Growth Corp Earnings Explainer

It was blood in the pot market streets today, and the site of the main...

Thursday, August 15, 2019, 05:02:09 PM

Thailand Decriminalizes Cannabis But Cautions Recreational Use

In a landmark move, Thailand Food and Drug Administration handed down a decision that removes...

Thursday, June 9, 2022, 03:11:00 PM

HHS Cannabis Rescheduling Recommendation Announcement Anticipated Soon

In a recent email from the US Department of Justice addressing the ongoing lawsuit surrounding...

Friday, January 12, 2024, 11:15:37 AM